Illumigyn
PrivateLast Round
Early Funding
Nov 3, 2021
Total Funding Raised
$38M
Company Overview
Illumigyn operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was an Early Funding round in November 2021.
Illumigyn is a health tech company which has developed the Gynescope, an FDA-cleared remote gynecological imaging platform designed to improve diagnostic accuracy for women's health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Telemedicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illumigyn Comparables
Compare Illumigyn with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Liger Medical | 88% | |
| Periwinkle Technologies | 84% | |
| GICMED | 78% |
For institutional investors. Book with your work email.
Illumigyn Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 3, 2021 | ||||
| Seed | Jun 9, 2016 |
For institutional investors. Book with your work email.
Illumigyn Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yozma Group Korea | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2021
$33M raised with Yozma Group Korea and Ubicom Holdings leading.
- Jun 9, 2016
Raised $5M with investors Ariel Katz and Ran Poliakine
For institutional investors. Book with your work email.
Illumigyn Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Illumigyn's valuation, stock price, and market status.
Is Illumigyn a public or private company?
Illumigyn is a private company.
What is the current stock price of Illumigyn?
Illumigyn is a private company, so its shares have no public market price. Caplight tracks Illumigyn's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Illumigyn worth (valuation)?
Valuation information for Illumigyn is not publicly available.
Can I buy Illumigyn stock?
Illumigyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Illumigyn's last funding round?
Illumigyn's most recent funding round was Early Funding on November 3, 2021.
Who are the main investors in Illumigyn?
Key investors in Illumigyn include Yozma Group Korea.
Will Illumigyn IPO soon?
No public IPO plans have been announced for Illumigyn.
How can I track Illumigyn secondary market activity?
Caplight tracks bids, offers, and trades in Illumigyn's shares on secondary markets.